Extracted from this filing and checked against the source text.
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
FORUM MARKETS Inc entered into Purchase Agreement with a certain institutional investor valued at approximately $6 million (effective 2022-12-20).
- Action
- entry
- Agreement
- equity purchase
- Counterparty
- a certain institutional investor
- Value
- approximately $6 million
- Effective
- 2022-12-20
Exact text from the filing
On December 20, 2022, 180 Life Sciences Corp., a Delaware corporation (the “ Company ”), entered into a securities purchase agreement (the “ Purchase Agreement ”) with a certain institutional investor (the “ Purchaser ”).
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
FORUM MARKETS Inc entered into Warrant Agent Agreement with Continental Stock Transfer & Trust Company (effective 2022-12-22).
- Action
- entry
- Counterparty
- Continental Stock Transfer & Trust Company
- Effective
- 2022-12-22
Exact text from the filing
On December 22, 2022, in connection with the closing of the offering, the Company entered into a Warrant Agent Agreement with Continental Stock Transfer & Trust Company, as warrant agent, in connection with each of the Pre-Funded Warrants and the Common Warrants (each, a “ Warrant Agent Agreement ” and, collectively, the “ Warrant Agent Agreements ”).
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
FORUM MARKETS Inc entered into Placement Agent Agreement with A.G.P./Alliance Global Partners (effective 2022-12-20).
- Action
- entry
- Agreement
- underwriting
- Counterparty
- A.G.P./Alliance Global Partners
- Effective
- 2022-12-20
Exact text from the filing
On December 20, 2022, the Company also entered into a placement agent agreement (the “ Placement Agent Agreement ”) with A.G.P./Alliance Global Partners (the “ Placement Agent ”).
View on SEC.gov